menu
    • menu

    Company profile for Atamyo Therapeutics

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases. A spin-off of gene therapy pioneer Genethon, Atamyo leverages unique expertise in AAV-based gene therapy and muscular dystrophies from the Progressive Muscular Dystrophies Laboratory at Genethon. Atamyo’s most advanced programs address different forms of limb-girdle muscular dystrophies (LGMD...
    Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases. A spin-off of gene therapy pioneer Genethon, Atamyo leverages unique expertise in AAV-based gene therapy and muscular dystrophies from the Progressive Muscular Dystrophies Laboratory at Genethon. Atamyo’s most advanced programs address different forms of limb-girdle muscular dystrophies (LGMD). The name of the company is derived from two words: Celtic Atao which means “Always” or “Forever” and Myo which is the Greek root for muscle.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Atamyo TherapeuticsFrance Flag
    Country
    Country
    France
    Address
    Address
    1 bis rue de l’Internationale 91000 EVRY
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://atamyo.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/atamyo-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genethon Highlights Atamyo's Gene Therapy, LGMD Progress
    Genethon Highlights Atamyo's Gene Therapy, LGMD Progress

    19 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250619068234/en/Clinical-Milestones-Vector-Innovation-Key-to-Gene-Therapy-GenoTher-Bioclusters-First-International-Summit-Atamyo-Therapeutics-Progress-for-LGMDs-Highlight-Genethons-Most-Recent-Newsletter

    BUSINESSWIRE
    19 Jun 2025
    Share Share
    FDA Clears IND for ATA-200 Gene Therapy for LGMD2C/R5
    FDA Clears IND for ATA-200 Gene Therapy for LGMD2C/R5

    12 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241112690214/en

    BUSINESSWIRE
    12 Nov 2024
    Share Share
    Atamyo Therapeutics Celebrates LGMD Awareness Day With Updates
    Atamyo Therapeutics Celebrates LGMD Awareness Day With Updates

    30 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240930155344/en

    BUSINESSWIRE
    30 Sep 2024
    Share Share
    Atamyo Therapeutics To Present At 6 Upcoming Conferences in US
    Atamyo Therapeutics To Present At 6 Upcoming Conferences in US

    16 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240916677302/en

    BUSINESSWIRE
    16 Sep 2024
    Share Share
    Dion Foundation and Atamyo Partner to Expand US Trial of ATA-200 for LGMD2C/R5
    Dion Foundation and Atamyo Partner to Expand US Trial of ATA-200 for LGMD2C/R5

    04 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240904042951/en

    BUSINESSWIRE
    04 Sep 2024
    Share Share
    Genethon's DMD Gene Therapy, Atamyo's LGMD, Cardiomyopathy Advances
    Genethon's DMD Gene Therapy, Atamyo's LGMD, Cardiomyopathy Advances

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603271912/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search